Trends in dermatomyositis- and polymyositis-related mortality in the state of São Paulo, Brazil, 1985-2007: Multiple cause-of-death analysis

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Santo, Augusto H ^a   Souza, José Maria P ^a   Pinheiro, Celso E ^b   Souza, Deborah C C ^c   Sato, Emilia I ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MINISTÉRIO DA SAÚDE   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CAUSE OF DEATH; CHILD; DEATH CERTIFICATE; DERMATOMYOSITIS; FEMALE; HUMAN; INFANT; MALE; MIDDLE AGED; MORTALITY; NEWBORN; POLYMYOSITIS; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; BRAZIL; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DEATH CERTIFICATES; DERMATOMYOSITIS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MORTALITY; POLYMYOSITIS; YOUNG ADULT;

EID: 77957683092     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-597     Document Type: Article

References (62)

1. Idiopathic inflammatory myopathies - myositis. C Dorph IE Lundberg, Best Pract Res Clin Rheumatol 2002 16 817 832 10.1053/berh.2002.0261 12473276
2. volution long terme au cours des myopathies inflammatoires idiopathiques. I Marie, Rev Méd Interne 2004 25 26 S28 10.1016/j.revmed.2004.04.009 (Pubitemid 38736982)
3. Long-term outcome in polymyositis and dermatomyositis. IM Bronner MFG van der Meulen M de Visser S Kalmijn WJ van Venrooij AE Voskuyl HJ Dinant WHJP Linssen JHJ Wokke JE Hoogendijk, Ann Rheum Dis 2006 65 1456 1461 10.1136/ard.2005.045690 16606652
4. Mortality in idiopathic inflammatory myopathies. IE Lundberg CJ Forbess, Clin Exp Rheumatol 2008 26 Suppl. 51 109 S114 19026152
5. Mortality in the rheumatic diseases. LF Callahan T Pincus, Arthritis Care Res 1995 8 229 241 10.1002/art.1790080406 8605261
6. Mortality in rheumatic diseases: introduction. T Pincus T Sokka, Clin Exp Rheumatol 2008 26 Suppl. 51 1 S4 19026139
7. The frequency of rheumatic diseases. S Cobb, Cambridge, Harvard University Press 1971 97
8. Prognosis and mortality of polymyositis and dermatomyositis patients. A Airio H Kautiainen M Hakala, Clin Rheumatol 2006 25 234 239 10.1007/s10067-005- 1164-z 16477398
9. Brasil. Lei n. 6.015, de 31 de dezembro de 1973. Dispe sobre os registros pblicos, e d outras providncias. Dirio Oficial da Unio 1973; 31 dez. http://www.planalto.gov.br/CCIVIL/LEIS/L6015.htm (accessed on 7 December 2007)
10. Conselho Federal de Medicina. Resoluço CFM no 1779/2005. Regulamenta a responsabilidade médica no fornecimento da Declaraço de bito. Publicada no D.O.U., 05 dez 2005, Seço I, p. 121. http://www.portalmedico.org.br/resolucoes/cfm/2005/1779-2005.htm (accessed on 7 August 2007)
11. Ministério da Sade, Conselho Federal de Medicina, Centro Brasileiro de Classificaço de Doenças. A declaraço de ábito: documento necessrio e importante [Death certificate: a necessary and important document] Brasília, Ministério da Saúde 2 2007
12. Ministério da Sade, Fundaço Nacional de Sade. Manual de Procedimentos do Sistema de Informaçes sobre Mortalidade [Procedures Manual of the Mortality Information System] Brasília: Ministério da Sade; Fundaço Nacional de Saúde http://bvsms.saude.gov.br/bvs/ publicacoes/sis-mortalidade.pdf (accessed on 24 January 2008).
13. International Classification of Diseases and Related Health Problems. World Health Organization, World Health Organization, Geneva 1993 Tenth Revision. Volume 2 Instruction Manual
14. Causas mltiplas de morte: formas de apresentaço e métodos de anlise [Multiple causes of death: presentation forms and methods of analysis]. AH Santo, PhD thesis São Paulo: Faculdade de Saúde Pblica, Universidade de São Paulo 1988
15. Analytical potential for multiple cause-of-death data. RA Israel HM Rosenberg LR Curtin, Am J Epidemiol 1986 124 161 179 3524199
16. Excess autoimmune disease mortality among school teachers. SJ Walsh LM DeChello, J Rheumatol 2001 28 1537 1545 11469459
17. Population-level influence of rheumatic arthritis on mortality and recent trends: a multiple cause-of-death analysis in France, 1970-2002. N Ziadé E Jougla J Coste, J Rheumatol 2008 35 1950 1957 18793005
18. Potencial epidemiolágico da utilizaço das causas mltiplas de morte por meio de suas mençes nas declaraçes de ábito, Brasil, 2003 [Epidemiological potential of multiple-cause-of-death data listed on death certificates]. AH Santo, Rev Panam Salud Publica 2007 22 178 186 18062852
19. Uso do microcomputador na seleço da causa bsica de morte [Use of a microcomputer in the selection of underlying cause of death]. AH Santo CE Pinheiro, Bol Oficina Sanit Panam 1995 119 319 327 7576192
20. Fundaço Sistema Estadual de Anlise de Dados. Populaço. Projeçes populacionais. http://www.seade.gov.br/produtos/projpop/ (accessed on 19 January 2009)
21. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death. World Health Organization, World Health Organization, Geneva 1997 1 Ninth Revision
22. International Classification of Diseases and Related Health Problems. World Health Organization, World Health Organization, Geneva 1992 1 Tenth Revision.
23. Equivalncia entre revises da Classificaço Internacional de Doenças: causas de morte [Bridge-coding between revisions of the International Classification of Diseases: causes of death]. AH Santo, Rev Saúde Pública 2000 34 21 28
24. International Classification of Diseases Translator: ninth and tenth revisions. World Health Organizatione, Geneva: WHO 1997
25. Comparative evaluation of underlying causes of death processed by the Automated Classification of Medical Entities and the Underlying Cause of Death Selection Systems. AH Santo CE Pinheiro EM Rodrigues, Rev Saúde Publica 1998 32 1 6
26. Avaliaço da qualidade da codificaço das causas de morte no Estado de São Paulo, Brasil [Quality evaluation of the coding of causes of death in the State of Sao Paulo, Brazil]. AH Santo, Informe Epidemiolágico do SUS 2000 9 189 198
27. Avaliaço da codificaço e do processamento das causas de morte pelo Sistema ACME no Estado de São Paulo, 1992 [Evaluation of coding and processing of causes of death by the ACME system in the State of Sao Paulo, 1992]. AH Santo, Thesis São Paulo: Faculdade de Saúde Pblica, Universidade de São Paulo 1994
28. Processamento de causas de morte em lote pelo sistema de seleço de causa bsica [Batch processing of causes of death by the underlying cause of death selection system]. CE Pinheiro AH Santo, Rev Saúde Publica 1998 32 72 73
29. Instruction Manual 2c: ICD-9 ACME decision tables for classifying the underlying causes of death, 1992. National Center for Health Statistics, Hyattsville, Maryland 1992
30. Instruction Manual 2c: ICD-10 ACME decision tables for classifying the underlying causes of death, 2008. National Center for Health Statistics, Hyattsville, Maryland 2008
31. Comparing hospital discharge records with death certificates: Can the differences be explained? (Theory and Methods). LA Johansson R Westerling, J Epidemiol Community Health 2002 56 301 308 10.1136/jech.56.4.301 11896139
32. Using multiple cause-of-death data to investigate associations and causality between conditions listed on the death certificate. MD Redelings M Wise F Sorvillo, Am J Epidemiol 2007 166 104 108 10.1093/aje/kwm037 17426040
33. Tabulador de causas mltiplas de morte [Multiple causes-of-death tabulator]. AH Santo CE Pinheiro, Rev Brasil Epidemiol 1999 2 90 97
34. Dermatomyositis. JP Callen, Lancet 2000 355 53 57 10.1016/S0140-6736(99) 05157-0 10615903
35. Dermatomyositis. RA Koller A Montemarano, Am Fam Physician 2001 64 1565 1572 11730311
36. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. I Marie E Hachulla PY Hatron MF Hellot H Levesque B Devulder H Courtois, J Rheumatol 2001 28 2230 2237 11669162
37. Polymyositis and dermatomyositis. M Dalakas R Hohlfeld, Lancet 2003 362 971 982 10.1016/S0140-6736(03)14368-1 14511932
38. Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up. KP Ng F Ramos SM Sultan DA Isenberg, Clin Rheumat 2009 28 947 953 10.1007/s10067-009-1181-4
39. Mortality from polymyositis and dermatomyositis in the United States, 1968-1978. MC Hochberg D Lopez-Acuna AM Gittelsohn, Arthritis Rheum 1983 26 1465 1471 10.1002/art.1780261208 6651895
40. Uses and significance of multiple cause tabulations for mortality statistics. HF Dorn IM Moriyama, Am J Pub Hlth 1964 54 400 406 10.2105/AJPH.54.3.400
41. Underlying and contributory causes of death. HF Dorn, Epidemiological approaches to the study of cancer and other chronic diseases National Cancer Institute, Haenszel W. Bethesda, Md, 1966 421 430
42. Trends in mortality rates comparing underlying cause and multiple-cause coding in an English population 1979-1998. MJ Goldacre ME Duncan P Cook-Mozaffari M Griffith, J Public Health Med 2003 25 249 253 10.1093/pubmed/fdg058 14575203
43. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. SM Sultan K Ioannou D Moss A Isenberg, Rheumatol 2002 41 22 26 10.1093/rheumatology/41.1.22
44. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. K Danká A Ponyi T Constantin G Borgulya G Szegedi, Medicine Baltimore 2004 83 35 42 10.1097/01.md.0000109755.65914.5e 14747766
45. Retrospective review of the clinical manifestations and outcomes in Puerto Ricans with idiopathic inflammatory myopathies. G Rios, J Clin Rheumatol 2005 11 153 156 10.1097/01.rhu.0000164820.46979.52 16357735
46. Adult-onset inflammatory myopathy: North Canterbury experience 1989-2001. SJ Lynn SM Sawyers PW Moller JL O'Donnell PT Chapman, Intern Med J 2005 35 170 173 10.1111/j.1445-5994.2004.00764.x 15737137
47. Survival, mortality and causes of death in inflammatory myopathies. C Torres R Belmonte L Carmona FJ Gámez-Reino M Galindo B Ramos A Cabello PE Carreira, Autoimmunity 2006 39 205 215 10.1080/08916930600622603 16769654
48. Influence of age on characteristics of polymyositis and dermatomyositis in adults. I Marie PY Hatron H Levesque E Hachulla MF Hellot U Michon-Pasturel H Courtois B Devulder, Medicine (Baltimore) 1999 78 139 147 10.1097/00005792- 199905000-00001 10352646
49. Ministério da Sade. Rede Interagencial de Informaçes para a Sade. Indicadores e Dados Bsicos - Brasil - 2007. Indicadores de Cobertura. Razo entre ábitos informados e estimados. http://tabnet.datasus.gov.br/ cgi/idb2007/f11a.htm (accessed on 18 May 2009)
50. Counting the dead and what they died from: an assessment of the global status of cause of death data. CD Mathers DM Fat M Inoue C Rao A Lopez, Bull World Health Organ 2004 83 171 177
51. Evaluation of cause-of-death statistics for Brazil, 2002-2004. E França DX Abreu C Rao AD Lopez, Int J Epidemiol 2008 37 891 901 18653516
52. Causas mal definidas e ábitos sem assistncia [Ill-defined causes of death and unattended deaths, Brazil, 2003]. AH Santo, Rev Assoc Med Bras 2008 54 23 28 10.1590/S0104-42302008000100016 18392482
53. Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma and polymyositis/dermatomyositis. GS Alarcán, Infect Dis Clin N Am 2006 20 849 875 10.1016/j.idc.2006.09.007 (Pubitemid 44762257)
54. Opportunistic infections in polymyositis and dermatomyositis. I Marie E Hachulla P Chérin M-F Hellot S Herson H Levesque PY Hatron, Arthritis Rheum 2005 53 155 165 10.1002/art.21083 15818648
55. Interstitial lung disease in polymyositis and dermatomyositis. M Fathi IE Lundberg, Curr Opin Rheumatol 2005 17 701 706 10.1097/01.bor.0000179949.65895. 53 16224246
56. Cardiac involvement in autoimmune myositis and mixed connective tissue diseases. IE Lundberg, Lupus 2005 14 708 712 10.1191/0961203305lu2205oa 16218472
57. The heart in dermatomyositis and polymyositis. IE Lundberg, Rheumatology 2006 45 v18 iv21 10.1093/rheumatology/kel311 16980718
58. Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. B Sigurgeirsson B Lindelöf O Edhag E Allander, N Engl J Med 1992 326 363 367 10.1056/NEJM199202063260602 1729618
59. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. CL Hill Y Zhang B Sigurgeirsson E Pukkala L Mellemkjaer A Airio SR Evans D Felson, Lancet 2001 357 96 100 10.1016/S0140-6736(00)03540-6 11197446
60. Cancer-associated myositis: clinical features and prognostic signs. A Ponyi T Constantin M Garami C Andrs B Tallai A Vncsa L Gergely K Danká Ann N Y Acad Sci 2005 1051 64 71 10.1196/annals.1361.047 16126945
61. Dermatomyositis and polymyositis associated with malignacy: a 21-year retrospective study. C Andrs A Ponyi T Constantin Z Csiki Szekanecz P Szodoray K Danká J Rheumatol 2008 35 438 444 18203322
62. Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis. L Fardet A Dupuy M Gain A Kettaneh P Chérin H Bachelez L Dubertret C Lebbe P Morel M Rybojad, Medicine 2009 88 91 97 10.1097/MD.0b013e31819da352 19282699